• Suhaib M Muflih, Sayer Al-Azzam, Sawsan Abuhammad, Sara K Jaradat, Reema Karasneh, and Mohammad S Shawaqfeh.
• Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
• Int. J. Clin. Pract. 2021 Jul 1; 75 (7): e14209.

BackgroundIn the telepharmacy model, the pharmacist can play a pivotal role in delivering pharmaceutical services for patients. However, evidence of pharmacists' impact on improving patient outcomes through disease outbreak through telepharmacy is sparse.ObjectivesThis study aims to examine pharmacists' attitudes towards clinical benefits and identify challenges regarding the use of telepharmacy during the COVID-19 pandemic in Jordan.MethodA cross-sectional survey design was used to recruit eligible participants from both hospital and community pharmacies.ResultsA total of 364 pharmacists agreed to participate in the study. The majority of the participants (70.6%) expressed favourable attitudes towards telepharmacy to accurately capture and report signs and symptoms of COVID-19. Almost 91% agreed that patients can receive immediate medical feedback while using telepharmacy services. Pharmacists (87%) emphasised their role in the monitoring of physiological parameters when entered by patients using telepharmacy technology. However, more than half of the participants reported that lack of reimbursement and evidence-based studies might hinder the use of telemedicine technology to deliver remote clinical services.ConclusionThe need for implementing telepharmacy technology has been further boosted because of its noticeable benefits in promoting convenient healthcare services remotely in emergency situations.© 2021 John Wiley & Sons Ltd.

10 keywords...

hide…